(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.11%) $79.09
(0.98%) $1.951
(0.93%) $2 332.50
(0.76%) $26.95
(1.24%) $966.70
(0.05%) $0.934
(0.11%) $11.04
(0.01%) $0.799
(0.27%) $93.51
5 days till quarter result
(tns 2024-05-07)
Expected move: +/- 7.51%
0.12% $ 8.50
Live Chart Being Loaded With Signals
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom...
Stats | |
---|---|
Volumen de hoy | 5 055.00 |
Volumen promedio | 23 725.00 |
Capitalización de mercado | 27.62M |
EPS | $0 ( 2024-03-13 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.245 |
ATR14 | $0.0410 (0.48%) |
Volumen Correlación
Liminal BioSciences Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
BCLI | 0.848 |
GOODM | 0.836 |
AEYE | 0.833 |
BUFF | 0.831 |
ACHV | 0.828 |
RDWR | 0.824 |
TBLD | 0.819 |
CMPR | 0.819 |
BOSC | 0.815 |
TAYD | 0.814 |
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Liminal BioSciences Inc Correlación - Moneda/Commodity
Liminal BioSciences Inc Finanzas
Annual | 2022 |
Ingresos: | $401 000 |
Beneficio Bruto: | $401 000 (100.00 %) |
EPS: | $-9.32 |
FY | 2022 |
Ingresos: | $401 000 |
Beneficio Bruto: | $401 000 (100.00 %) |
EPS: | $-9.32 |
FY | 2021 |
Ingresos: | $643 000 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $0.430 |
FY | 2020 |
Ingresos: | $3.32M |
Beneficio Bruto: | $1.28M (38.71 %) |
EPS: | $-4.83 |
Financial Reports:
No articles found.
Liminal BioSciences Inc
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico